Default

Get an inside look at our central laboratory in Indianapolis to see how new automation is improving efficiency and capacity in our hematology and testing labs.

See how state-of-the-art technologies at our Indianapolis central lab enhance sample processing to better support of your mission and bring new therapeutics to patients.

In the evolving landscape of medical devices, Labcorp's Chromosomal Aberration Assay plays an important role in the assessment of genotoxic potential of these devices, evaluating their safety at a chromosomal level.

Our new automation integrates robotic sample processing and pre-analytical tasks like centrifugation to enable seamless progression of samples through the lab. Watch the video to learn more about our latest investments in lab automation.

Labcorp supported a complex regional clinical trial involving flow cytometry for a leading Japanese pharmaceutical company, providing global central laboratory network and logistics services. By leveraging our global central lab facilities with standardized assays, Labcorp provided consistent, reliable and combinable data regardless of the trial location.

A known structural component of gram-negative bacteria, endotoxins can elicit strong inflammatory responses and fever if they enter the human bloodstream.

We have evaluated the use of rapidly growing mycobacterium (RGM) media in disinfection efficacy studies and shown its capacity to improve the accuracy of studies regarding undesirable contaminants.

Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Choosing the right partner-with expertise in antibody and tissue selection, cutoff design and regulatory approvals-is key to advancing global CDx programs.